Логотип Артген
  • About
    • Company Strategy
    • Group Structure
    • Board of directors
    • Management
    • Career
    • Contacts
  • Development
    • Drugs
    • Medical devices
    • Medical services
  • Biotech valuation
  • Activity
    • Areas of activities
    • Research and development (R&D) stages
    • Ecosystem
    • Acceleration
    • Commercialization
  • Investor
    • Disclosure of information
  • News
En
RU CN
  • Главная
  • News
  • News

    News, press releases, events, publications

    All categories
    All categories News Press releases Press about us
    Portfolio
    Portfolio Histograft Betuvax Nextgen Gemabank Genetico Biotechnology Developments Genotarget Reprobank Vitacel
    • 18.07.2024
      Press releases
      ACRA upgraded the credit rating of Artgen Biotech to BBB-(RU), and the forecast is «Stable»
    • 11.07.2024
      Press releases
      Histograft received a patent in the USA
    • 10.07.2024
      Press releases
      Rostec received permission to conduct clinical trials of Russia’s first vaccine against influenza and coronavirus
    • 08.07.2024
      Press releases
      ACRA confirmed the credit rating of International Medical Center for Biomaterials PJSC at BB+(RU), and the forecast is «Stable»
    • 04.07.2024
      News
      Mr. Mishustin spoke about the goals of the “New Health Saving Technologies” national project.
    • 03.07.2024
      News
      Cifra broker published a quarterly review of Artgen Biotech
    • 02.07.2024
      Press releases
      Genetico shareholders approved the annual report for 2023
    1 … 3 4 5 6 7 … 17
    footer logotype
    Follow us
    • Telegram
    • VK
    • Interfax-CRCI
    Moscow, Gubkina street, 3, b.1
    • info@artgen.ru
    • +7 (495) 646-80-76
    ©2003-2025 Artgen biotech
      • About the Company
      • Company Strategy
      • Group Structure
      • Board of Directors
      • Management
      • Career
      • Contacts
      • Development Portfolio
      • Drugs
      • Medical Devices
      • Medical Services
      • Activity
      • Areas of activities
      • Research and development (R&D) stages
      • Ecosystem
      • Acceleration
      • Commercialization
      • Investors
      • Biotech Valuation
      • Disclosure of information
      • Contacts
    • About the Company
      • About
      • Company Strategy
      • Group Structure
      • Board of Directors
      • Management
      • Career
      • Contacts
    • Development Portfolio
      • Drugs
      • Medical Devices
      • Medical Services
    • Activity
      • Areas of activities
      • Research and development (R&D) stages
      • Ecosystem
      • Acceleration
      • Commercialization
    • Biotech Valuation
    • Investors
      • Disclosure of information